The Centers for Medicare & Medicaid Services is committed to moving 50% of its fee-for-service care to value-based alternative payment models by 2018. The Comprehensive Care for Joint Replacement model is a mandatory agency program that bundles lower extremity joint arthroplasties into episodes of care that extend from the index admission to 90 days after discharge. This program, which began on April 1, 2016, includes many of the hospitals that perform total joint arthroplasties. As with other bundled payment arrangements, this model is built around seven principles that orthopaedic surgeons should be familiar with to maximize participation.
From the Department of Orthopaedic Surgery, NYU Langone Medical Center, New York, NY.
Dr. Bosco or an immediate family member has received royalties from Genovel; is a member of a speakers' bureau or has made paid presentations on behalf of Pacira Pharmaceuticals; serves as a paid consultant to Genovel, Labrador Healthcare, and Medtronic; and has stock or stock options held in Genovel. Dr. Iorio or an immediate family member serves as a paid consultant to DJO Global, MCS ActiveCare, Medtronic, Muve Health, and Pacira Pharmaceuticals; has stock or stock options held in Force Therapeutics, MCS ActiveCare, Muve Health, URXmobile, and Wellbe; has received research or institutional support from Bioventus, Ferring Pharmaceuticals, Orthofix, Orthosensor, Pacira Pharmaceuticals, and Vericel; and serves as a board member, owner, officer, or committee member of the American Association of Hip and Knee Surgeons, The Hip Society, and The Knee Society. Neither Mr. Harty nor any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article.